NCT03269643View on ClinicalTrials.gov

Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients Patients

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

November 24, 2017

Study Completion Date

November 24, 2017

Conditions
Vital Sign Monitoring
Interventions
DEVICE

Investigational Group

The RHEA device and Philips Patient Monitor MX400 are used to monitor the heart rate (HR) and respiratory rate (RR) of participants.

DEVICE

Reference group

The reference device Earlysense 2.0 system(vital sign monitoring system) and Philips Patient Monitor MX400 are used to monitor the heart rate (HR) and respiratory rate (RR) of participants.

Trial Locations (1)

20770

MedStar Health Research Institute, Inc., Washington D.C.

Sponsors
All Listed Sponsors
collaborator

Medstar Health Research Institute

OTHER

lead

Darma Inc.

INDUSTRY